We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 60,335 | 08:00:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
31/3/2020 09:18 | >> tidy Nothing proven in clinical trials yet. What you say is probably correct but it is important to stress the results haven't been confirmed yet. The COPD trial result would confirm that but that is going to come out after the Covid 19 trial result now. | nobbygnome | |
31/3/2020 09:12 | They. Know SNG001 already works on C viruses.A battery operated nebuliser is used. Wait for all the data is sought which they can correspond to data already gained from previous virus trials. SNG001 has at least 6 viruses including coronaviruses it works on. Follow the twitter links I posted last night for list of success on viruses | tidy 2 | |
31/3/2020 09:12 | All positive but the most important thing is for the testing to go well and be effective. The. We're really at the races! | tickboo | |
31/3/2020 09:12 | if tests come back with good results no more testing will be required by the yanks this will be fasttracked and used , desperate times,desperate measures , rules will be adjusted to suit IMO | d1nga | |
31/3/2020 09:10 | Tickboo The Americans are already receptive. :o) _______ Bill Gates Foundation funds WHO with tens of $ Billions. Bill Gates Foundation collaborates with the FDA for public health and have an MOU with the FDA. Bill Gates refers in an interview a few days ago to the focus on the top three or four solutions to COV19. SNG is highlighted by WHO as one of the four possible solutions. Bill Gates and Mark Zuckerberg also join forces to combat COV19 SNG is already mixing with the right crowd where tens of £ Billions are available for investment in this area of their focus, COV19, and where £ Billionaire influencers already have affiliations with the relevant authorities . :o) | jev1 | |
31/3/2020 09:08 | 100 not 200. | tidy 2 | |
31/3/2020 09:06 | One would assume if initial tests in the U.K. (before all 200 completed) come back positive the Americans may well be receptive to testing in their hospitals too and fast track - At the time of the MERS-CoV outbreak in 2013, Synairgen collaborated with the National Institutes of Health (NIH) in the US to show that SNG001 could protect against MERS-CoV infection of lung cells in vitro. | tickboo | |
31/3/2020 09:05 | Watch the video I posted last night hear it from the virologist himself. They will not manage a vaccine for this they tried for 7 years with SARS and gave up in the end. He says treatment only will work. Plus even if they had a vaccine it would not work for everyone as proved with the influenza vaccine. They are hit and miss. SNG001 may be the only successful treatment and possible preventative treatment. Block buster drug. | tidy 2 | |
31/3/2020 09:04 | Christ there are some sphincters on here. | talk2dubya | |
31/3/2020 09:00 | 1627 WHY DO THEY THINK THAT TIDY? | hazl | |
31/3/2020 08:55 | Well done nobby, good call. | fatnacker | |
31/3/2020 08:55 | Great that SNG001 has already had results against 'viral load', one of the reasons with COV19 for the severe infections, the amount of the virus that anyone comes into contact with. From the RNS: _______ Two Phase II clinical trials in asthma showed that inhaled SNG001 treatment activated antiviral pathways in the lung along with improving lung function in patients with a respiratory viral infection. We have also shown that treatment with inhaled SNG001 reduced lung viral load and lung pathology in an in vivo swine flu driven model of viral pneumonia. At the time of the MERS-CoV outbreak in 2013, Synairgen collaborated with the National Institutes of Health (NIH) in the US to show that SNG001 could protect against MERS-CoV infection of lung cells in vitro. | jev1 | |
31/3/2020 08:53 | Expect you're a loner ........ filtered | jrlomax | |
31/3/2020 08:49 | All I'm expecting from you Max is more BS. | jev1 | |
31/3/2020 08:48 | Expect a retrace imho | maxplus2 | |
31/3/2020 08:42 | Synairgen has initiated a further six trial sites | tidy 2 | |
31/3/2020 08:40 | True relate in effect. Top virologist states Treatment only for COVID19 there will never be a vaccine for this. Hello SNG001 | tidy 2 | |
31/3/2020 08:38 | I sold mine holding. Not bad for 1 week work | maxplus2 | |
31/3/2020 08:37 | level 25 V 1 Guys360p per share just a matter of time. Fully cashed up with £4m SNG001 being stock piled and no debt. | tidy 2 | |
31/3/2020 08:37 | Same, never been offered the ask price when the spread is nearly 10%! Normally a sign that this is going much higher... desperate for shares. | 74tom | |
31/3/2020 08:34 | Offered 69p to sell | herb clark | |
31/3/2020 08:34 | Sure you did Max .... pull the other one. | jev1 | |
31/3/2020 08:32 | 360p ps target post trial successSNG001 we already know works on coronaviruses also. NPV 120p NOW + 240p ps post trial success. | tidy 2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions